TRIB
Trinity Biotech
TRIB
TRIB
20 hedge funds and large institutions have $5.93M invested in Trinity Biotech in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $5.96M → $5.93M (-$33.4K)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
76% less call options, than puts
Call options by funds: $4K | Put options by funds: $17K
Holders
20
Holding in Top 10
1
Calls
$4K
Puts
$17K
Top Buyers
| 1 | +$106K | |
| 2 | +$14.8K | |
| 3 | +$9.51K | |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$1.79K |
Top Sellers
| 1 | -$71.3K | |
| 2 | -$56.5K | |
| 3 | -$49.1K | |
| 4 |
AWS
Atria Wealth Solutions
New York
|
-$32.2K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$14.1K |